Industries > Pharma > Vaccine Sales Market Report 2022-2032

Vaccine Sales Market Report 2022-2032

Forecasts by Indication (Pneumococcal, Rotavirus, Influenza, Hepatitis, COVID-19, Measles, Mumps & Varicella, Typhoid, Meningococcal, DPT, Others), by Route of Administration (Intramuscular, Subcutaneous, Oral), by Type (Inactivated, Live Attenuated, Toxoid, Recombinant/Conjugate/Subunit), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), by Age Group (Paediatrics, Adults) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 21 April 2022
PAGES: 622
PRODUCT CODE: PHA1165
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1165 Categories: , Tags: , , ,

Use of Adjuvants in Vaccines to Offer Lucrative Growth Prospects
The growing usage of integrated unit vaccinations is propelling the adjuvant industry forward. The need for different adjuvants is increasing as consumption rises. More development is projected in the next years, which will raise the need for adjuvants. The market is predicted to develop at a modest pace, owing to the rising use of biologics and biosimilars, as well as increased R&D in vaccines throughout the globe. Unmet demand for specialised vaccinations, higher government immunisation recommendations, technical advancements, and greater usage of combination and synthetic vaccines are all factors that contribute to the development of the adjuvants vaccine market.

Growing Vaccination Awareness to Boost Market Growth
Over the past years, national and local bodies have taken efforts to aware public of benefits of vaccine immunization. The media plays an important role in spreading awareness among the general public regarding pros and cons of vaccine immunization. With the growing level of medica coverage in rural parts of developing and under-developed economies, the market for live vaccines is anticipated to witness lucrative opportunities over the forecast period.

What are the Growth Drivers for Vaccine Sales Market?
• Rising Focus and Government Support on Immunization Programs
• Growing Investment in Vaccine Development
• Increasing Company Initiatives to Enhance Vaccine R&D
• High Prevalence of Infectious Diseases
• Technological Advancements in Vaccine Administration
• Rapid Need of Immunization
• Strong Supply Backed Up by Robust R&D to Drive the Market

What are the Challenges for Vaccine Sales Market?
• Inadequate Reimbursement Coverage
• High Cost of Vaccine Development
• Long Timelines of Vaccine Manufacturing Hinder the Growth of the Vaccines Market
• Stringent Government Regulations for Approval

What are the Market Opportunities?
• High Growth Prospects in Emerging Markets
• Focus on Therapeutic Vaccines
• Use of Adjuvants in Vaccines
• Government Support for Future Vaccine R&D

Long Timelines of Vaccine Manufacturing Projected to Hinder Vaccines Market Growth
Vaccine development is seen as an expensive, difficult, and time-consuming process because to the intricacy of manufacturing and accompanying processes, which may take up to 10–15 years. Due to the endless combinations of biological ingredients, microorganisms, equipment employed, ambient conditions, and culture stages, results may vary greatly throughout manufacturing. Furthermore, the reagents and procedures needed to monitor culture parameters add to the process’ complexity, prolonging production times.

Furthermore, product approvals from regulatory bodies take longer since the authorities evaluate the product’s quality and effectiveness, as well as the manufacturing process. After the producers show enough pre-clinical evidence on the vaccines’ safety to confirm the vaccines’ action in people, the vaccines start clinical trials. Even after approval, each year, vaccination batches are evaluated for safety and stability to guarantee compliance with regulatory requirements. Furthermore, the longer the deadlines, the greater the production cost, which restricts new manufacturers from entering the market, stifling growth.

Discover how to stay ahead
Our 620+ page report provides 640+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Vaccine Sales Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and sub-markets

Indication
• Pneumococcal
• Rotavirus
• Influenza
• Hepatitis
• COVID-19
• Measles
• Mumps & Varicella
• Typhoid
• Meningococcal
• DPT
• Others

Route of Administration
• Intramuscular
• Subcutaneous
• Oral

Type
• Inactivated
• Live Attenuated
• Toxoid
• Recombinant/Conjugate/Subunit

Distribution Channel
• Hospital & Retail Pharmacies
• Government Suppliers
• Others

Age Group
• Pediatrics
• Adults

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

• North America
• U.S.
• Canada

• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• Australia
• Rest of Asia Pacific

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Vaccine Sales Market Report 2022-2032
Need industry data? Please contact us today.

Leading companies and the potential for market growth
Overall world revenue for Vaccine Sales Market will surpass $xx billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Vaccine Sales market. Some of the companies profiled in this report include Bavarian Nordic, Bharat Biotech, CSL Limited, Daiichi Sankyo Co., Emergent BioSolutions Inc., GlaxoSmithKline plc, Inovio Pharmaceuticals, Inc., J&J, Merck Co., Inc., Mitsubishi Tanabe Pharma Corporation, Moderna, Inc., Novavax, Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Sun Pharmaceutical Industries Ltd., AstraZeneca PLC, Sinopharm, SINOVAC, and Takeda Pharmaceutical Company Limited among other prominent players.

How the Vaccine Sales Market report helps you
In summary, our 620+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Vaccine Sales Market, with forecasts for 11 indications, 3 route of administration, 4 types, 3 distribution channel, and 2 age groups , each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2032 for 5 regional and 20 key national markets– See forecasts for the Vaccine Sales market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, and South-East Asia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the companies involved in the Vaccine Sales Market. Some of the company’s profiled in this report include Bavarian Nordic, Bharat Biotech, CSL Limited, Daiichi Sankyo Co., Emergent BioSolutions Inc., GlaxoSmithKline plc, Inovio Pharmaceuticals, Inc., J&J, Merck Co., Inc., Mitsubishi Tanabe Pharma Corporation, Moderna, Inc., Novavax, Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Sun Pharmaceutical Industries Ltd., AstraZeneca PLC, Sinopharm, SINOVAC, and Takeda Pharmaceutical Company Limited, among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Vaccine Sales Market and leading companies. You will find data, trends, and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Vaccine Sales Market Report 2022-2032: Forecasts by Indication (Pneumococcal, Rotavirus, Influenza, Hepatitis, COVID-19, Measles, Mumps & Varicella, Typhoid, Meningococcal, DPT, Others), by Route of Administration (Intramuscular, Subcutaneous, Oral), by Type (Inactivated, Live Attenuated, Toxoid, Recombinant/Conjugate/Subunit), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), by Age Group (Paediatrics, Adults) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Vaccine Sales Market Report 2022-2032


Download sample pages

Complete the form below to download your free sample pages for Vaccine Sales Market Report 2022-2032


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ